Transforming growth factor-b-induced (TGFΒI) is considered to be a vital gene in several carcinomas. In this study we determined the effect of TGFBI on the proliferative and metastatic potential of human urothelial carcinoma (UC) cells as well as its mRNA and protein expression, which were detected by RT-PCR and western blot, respectively. UC cell proliferation was analyzed by WST-1 assay and Hoechst 33258 staining. The effect of TGFBI on UC cell metastasis was analyzed using adhesion, migration and invasion assays. We found that TGFBI increased the proliferation of UC cells. Moreover, TGFBI enhanced the adhesion, migration and invasion of UC cells by upregulating MMP-2, MMP-9 and calpain-2 expression. We evaluated the effect of Epirubicin (EPI) on the regulation of TGFBI expression and found that TGFBI acts as a downstream target of EPI and is suppressed by EPI in UC cells.
Transforming growth factor-b-induced (TGFΒI) is considered to be a vital gene in several carcinomas. In this study we determined the effect of TGFBI on the proliferative and metastatic potential of human urothelial carcinoma (UC) cells as well as its mRNA and protein expression, which were detected by RT-PCR and western blot, respectively. UC cell proliferation was analyzed by WST-1 assay and Hoechst 33258 staining. The effect of TGFBI on UC cell metastasis was analyzed using adhesion, migration and invasion assays. We found that TGFBI increased the proliferation of UC cells. Moreover, TGFBI enhanced the adhesion, migration and invasion of UC cells by upregulating MMP-2, MMP-9 and calpain-2 expression. We evaluated the effect of Epirubicin (EPI) on the regulation of TGFBI expression and found that TGFBI acts as a downstream target of EPI and is suppressed by EPI in UC cells.
EPI is more effective in inhibiting the proliferation and metastasis of UC cells with high TGFBI expression. This study demonstrates that TGFBI might lead to tumorigenesis and progression of UC and those cells with high TGFBI expression may be vulnerable to relapse. EPI could prove to be a therapeutic option in patients with high TGFBI expressing UC cells.
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| INTRODUCTION
Bladder cancer is second only to prostate cancer as the most common urologic malignancy in men, and urothelial carcinoma (UC)
accounts for approximately 90% of all bladder cancers. 1 Among UC, 70%-80% are non-muscle-invasive and the remainder are muscleinvasive. Between 50% and 70% of non-muscle-invasive UC have a high rate of recurrence and 10%-30% will progress to muscle-invasive UC. 2 Transurethral resection (TUR) is the primary regimen for patients with non-muscle-invasive UC 3 and the 5-year overall survival rate for non-muscle-invasive UC has been reported to be 90%, 60%, 35% and 25% for non-muscle-invasive, pT2, pT3 and pT4 UC, respectively. 4, 5 Although regular cystoscopic surveillance is essential for early tumor detection, the mortality rate of UC patients is increasing due to tumor metastasis. The molecular mechanisms responsible for the metastasis of UC is still unclear, thus further study should be elucidated to overcome the proliferation and metastasis of UC, it is useful to the development of novel approaches and seeking improved therapeutic strategies. 6, 7 Transforming growth factor-b-induced (TGFΒI), also known as BIGH3, is a target of transforming growth factor-b1 (TGF-b1). 8 TGFBI plays an important role in the activation of cell differentiation, proliferation, adhesion and migration; however, conflicting roles have been Shang and Song contributed equally to this study and should be considered as co-first authors.
-
reported with respect to tumorigenesis and progression. 9, 10 and the rate of positive urine cytologies. Moreover, the combined examination of urine cytology with TGF-b1 and VEGF has achieved higher sensitivity in the detection of UC. 24 Another study suggested that TGF-b1 promotes cell migration and invasion of UC cells by increasing fascin1 expression. 25 As a substrate for TGF-b1, the concentration of TGFBI was also elevated in the serum and urine of patients with UC, and mRNA expression was increased in muscleinvasive UC. 26 These findings suggest that TGFBI may play an important role in tumorigenesis and progression of UC; however, to date, only limited information is available on TGFBI functionality in UC.
In this study we determined the effect of TGFBI on the proliferative and metastatic potential in human UC. Because TGFBI is involved in the proliferation, adhesion, migration and invasion of UC cells, we speculate that TGFBI may enhance metastasis of UC and that TGFBI serves as a candidate marker for the prediction of UC recurrence and a therapeutic target in treating UC.
| MATERIALS AND METHODS

| Cell culture
Two UC cell lines, RT112 and 253J, were purchased from the ATCC and cultured in 10% heat-inactivated FBS, supplemented with 1% non-essential amino acids, RPMI-1640 medium, 25 mmol/L HEPES, 2 mmol/L L-glutamine, and 100 units/mL penicillin or 100 lg/mL streptomycin (Invitrogen). All UC cell lines were maintained as monolayers in 10-cm plastic dish and cultured at 37°C in a humidified atmosphere of 5% CO 2 .
| Reverse transcription-PCR
Total RNA from UC cells was extracted using Trizol Reagent (Invitrogen) according to the manufacturer's instructions; first-strand complementary DNA (cDNA) was reverse-transcribed using a cDNA Synthesis Kit (Amersham Biosciences). The cDNA was used as the template and was amplified by PCR according to the manufacturer's instructions. The PCR products were visible by agarose gel electrophoresis. GAPDH was used as the internal control to normalize variances, and the primer sets used in this study are shown in Table 1 .
| Western blot
Total protein was isolated and an equal quantity of protein lysates 
| siRNA and transfection
All siRNA oligonucleotide sequences were designed using siDirect software and the oligonucleotide sets used in this study are shown in Table 1 
| Proliferation analysis
The effect of TGFBI on the proliferative ability of UC cells was analyzed using the WST-1 assay. 
| Cell migration assay
Chemotaxis was analyzed using the transwell system (Poretics, Livermore, CA, USA) containing 8 lm-pore polycarbonate membrane filters. UC cells were harvested and re-suspended in medium with 0.05% FBS, then 1 9 10 4 cells were seeded into the upper wells. After continuous incubation at 37°C for 24 hour, the membrane was removed and fixed with 70% ethanol at À20°C for 30 minute, and the membrane was harvested and stained with Hoechst 33258. All experiments were performed thrice.
| Cell invasion assay
Cell invasion was analyzed using a transwell system incorporating a polycarbonate filter membrane (Corning). A thin gel layer was formed by adding 12.5 lg Matrigel and 50 lL PBS on the filter and dried overnight. A total of 1 9 10 5 UC cells were harvested in 100 lL serum-free medium and then seeded to the upper chamber of the transwell system. After 24-hour incubation at 37°C, the UC cells that penetrated to the lower surface of the filter were harvested and stained with Hoechst 33258. All experiments were replicated 3 times.
| Statistical analysis
All results are expressed as the mean AE SD. Statistical significance was determined by Student's t test, and a P-value ≤ .05 was considered significant.
3 | RESULTS
| Transforming growth factor-b-induced enhances the proliferative ability of urothelial carcinoma cells
The expression of TGFBI was decreased using RNAi, and the expression of TGFBI was also increased by transfection with a vector containing the full-length cDNA for TGFBI. 
| Epirubicin decreases the expression of transforming growth factor-b-induced
Epirubicin is the first-line treatment for patients with bladder UC after TUR. 27 Although EPI can effectively reduce the recurrence rate of UC, the mechanism of EPI is still unclear. We found that EPI caused time-dependent cell growth suppression in 2 UC cell lines ( Figure 5A ). We also evaluated the effect of EPI (4 lmol/L for 48 hour) on the regulation of TGFBI expression by RT-PCR (Fig- ure 5B) and western blot analysis ( Figure 5C ). Our results suggest that EPI can significantly downregulate the expression of TGFBI in 2 UC cells. These findings suggest that TGFBI acts as a downstream molecule of EPI, and that EPI exerts its biological functions by decreasing the expression of TGFBI in human UC.
| Transforming growth factor-b-induced affects
Epirubicin-induced tumor-suppressive functions 26 indicate that the expression of TGFBI is elevated in the serum and urine of patients with UC; moreover, mRNA expression is also increased in muscle-invasive UC, which suggests that TGFBI may prove useful as a diagnostic or prognostic marker for UC. 26 The roles of TGFBI in UC are still indistinct, and the functions of TGFBI in UC should be further determined.
In the present study we evaluated the effect of TGFBI on the proliferation of UC cells. We found that TGFBI increased the UC of various signals. 35 Calpain-2 is a calcium-dependent thiol proteinase, which consists of a regulatory subunit and a catalytic subunit. 36 Calpain-2 is activated by millimolar levels of Ca 2+ . 37 It has been reported that calpain-2 mediates the invasion of glioma cells. 38 Our results indicate that TGFBI increases the expression of MMP-2, MMP-9 and calpain-2. TGFBI may promote metastasis, by regulating the secretion of MMP and calpain-2 in human UC.
Routine intravesical instillation with EPI has been widely performed to reduce the recurrence of UC following TUR. Although EPI chemotherapy has achieved an average 16 months of mean diseasefree survival, and suppressed the progression and recurrence in patients with non-muscle-invasive UC, 39 acquired resistance to EPI is still a barrier to achieving successful treatment of UC. 40 Some studies with combination treatments have shown antitumor drug action and possible synergistic effects against UC. Ciprofloxacin has been shown to synergistically increase EPI-induced apoptosis in UC cell lines, 41 and icaritin acts synergistically with EPI to suppress UC cell growth through inhibition of autophagy. 40 However, the F I G U R E 6 TGFBI affects EPI-induced tumor-suppressive functions. EPI caused dose-dependent cell growth suppression in 2 UC cell lines, and an increased susceptibility to EPI was observed in UC cells with a high level of TGFBI expression (A). EPI had higher suppressive ability of adhesion (B), migration (C) and invasion (D) in high TGFBI-expressing UC cells. All experiments were performed in triplicate and the error bar represents the SD; only the results for RT112 are shown. *P < .05 vs control molecular mechanisms of EPI in UC remain unclear. In this study we examined the effect of EPI on the regulation of TGFBI expression.
TGFBI acts as a downstream target of EPI, and EPI can suppress the expression of TGFBI in UC cells. In addition, we evaluated the effect of TGFBI on EPI-induced tumor-suppressive functions. Our results suggest that EPI is more effective in inhibiting the proliferation and metastasis of UC cells with high TGFBI expression. These findings indicated that decreased expression of TGFBI may contribute to the resistance to EPI therapy.
In conclusion, we found that TGFBI plays an important role in the proliferation and metastasis of UC, and that TGFBI might lead to tumorigenesis and progression of UC. It is also an intriguing possibility that UC cells with high TGFBI expression may be vulnerable to relapse. TGFBI may be a potential marker for recurrence and EPI could be a therapeutic option for UC patients with high TGFBI expression. The molecular mechanisms underlying TGFBI in UC warrant further investigation.
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